(lp0
S'Oculus Innovative Sciences Announces Corporate Name Change to Sonoma ... GlobeNewswire  - Dec 5, 2016 PETALUMA, Calif., Dec. 05, 2016  -- Oculus Innovative Sciences, Inc. , a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and&nbsp;...'
p1
aS'Sonoma Pharmaceuticals Announces Results from SebuDerm Gel Study in ... GlobeNewswire  - Mar 16, 2017 PETALUMA, Calif., March 16, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of&nbsp;...'
p2
aS'Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2017 Financial Results ... GlobeNewswire  - Jan 26, 2017 PETALUMA, Calif., Jan. 26, 2017  -- Sonoma Pharmaceuticals, Inc. , today announced that the financial results for its fiscal third quarter 2017, ended December 31, 2016, will be released after the U.S.'
p3
aS'7.919 MarketWatch - Jan 1, 2017 Sonoma Pharmaceuticals Inc. Watchlist CreateSNOAAlert. Closed. Last Updated: Mar 16, 2017 3:59 p.m.. $ 7.919. 0.569 7.74%.'
p4
aS'BRIEF-Oculus Innovative Sciences announces corporate name change to Sonoma ... Reuters - Jun 29, 2015 TOKYO, March 13 Asian shares rose on Monday, taking their cue from gains on Wall Street after strong U.S. job data, though the mood was cautious as oil prices plunged to 3 1/2-month lows on fresh worries of oversupply.'
p5
aS'Technical Levels in View For Sonoma Pharmaceuticals Inc  Baxter Review - 14 hours ago Sonoma Pharmaceuticals Inc  has a current 14-day RSI reading of 68.9, the 7-day is 72.16, and the 3-day is 73.12. The RSI, or Relative Strength Index is a popular oscillating indicator among traders and investors.'
p6
aS'Sonoma Pharmaceuticals Appoints Marc Umscheid as Chief Strategy and Marketing ... GlobeNewswire  - Jan 31, 2017 PETALUMA, Calif., Jan. 31, 2017  -- Sonoma Pharmaceuticals, Inc. , today announced the appointment of Marc Umscheid as chief strategy and marketing officer.'
p7
aS'Is Sonoma Pharmaceuticals Inc  Finding its Groove? Business Review - Mar 15, 2017 Over the past five sessions, Sonoma Pharmaceuticals Inc  has pulled in nice gains, moving higher 6.80% over the past five sessions.'
p8
aS'Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 GlobeNewswire  - Feb 9, 2017 09, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced&nbsp;...'
p9
aS'Zacks: Sonoma Pharmaceuticals Inc  Given Consensus Recommendation of ... Chaffey Breeze - Mar 10, 2017 Sonoma Pharmaceuticals logo Shares of Sonoma Pharmaceuticals Inc  have been assigned an average broker rating score of 1.00  from the one brokers that cover the stock, Zacks Investment Research reports.'
p10
a.